News | September 27, 2024
USV launches Q rite tablets for treatment of rare aprhythmia in heart patients
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
This approval reflects company’s unwavering commitment that the quality assurance
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The acquisition is based on an enterprise value of Rs. 1,660 crore
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
Subscribe To Our Newsletter & Stay Updated
